IP Library › Granted Patent US 10,724,027
Granted Patent B2
US 10,724,027 · App. 14/029,651 · Granted Jul 28, 2020

Method for making pluripotent stem cells

Inventor: Cynthia Bamdad (Waltham, MA)
Assignee: MINERVA BIOTECHNOLOGIES CORPORATION
C12N11/06A61K31/7088C07K16/2863C07K16/3092C12N5/0606C12N5/0696C12Q1/6881C07K2317/35C07K2317/75C12N2500/98C12N2501/115C12N2501/727C12N2533/50C12Q2600/158C12Q2600/178
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,724,027
App. No.
14/029,651
Granted
Jul 28, 2020
Kind
B2
Abstract

The present application discloses a method for inducing cells to gain characteristics of naïve stem cell state comprising culturing the cells in the presence of a MUC1* activator.

Claims (13)

1. An article comprising a stem cell proliferation surface without feeder layer, to which is bound an agent that binds to a cell surface molecule that is present on stem cells or progenitor cells, wherein the agent is monoclonal antibody that binds to PSMGFR, wherein the monoclonal antibody has the following Kappa Chain Variable Region CDR sequences:

(SEQ ID NO: 20)

CDR1: RSSQTIVHSNGNTYLE;

(SEQ ID NO: 21)

CDR2: KVSNRFS;

and

(SEQ ID NO: 22)

CDR3: FQGSHVPFT.

2. The article according to claim 1 , wherein the surface comprises from at least about 0.5% Nitrogen (N), at least about a sum of Oxygen (O) and Nitrogen (N) of greater than or equal to 17.2%, and a contact angle of at least about 13.9 degrees.

3. The article according to claim 1 , wherein the surface is Vita or Vita-like surface.

4. The article according to claim 1 , wherein the cell surface molecule is MUC1.

5. The article according to claim 4 , wherein the cell surface molecule is MUC1*.

6. The article according to claim 5 , wherein the cell surface molecule is consists essentially of the PSMGFR sequence.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 7, 2019
From: BAMDAD, CYNTHIA
To: MINERVA BIOTECHNOLOGIES CORPORATION
Reel/Frame 048271/0550 →
Continuity (6)
Continuation PCTUS2012029706 · Mar 19, 2012
Provisional Application 61453917 · Mar 17, 2011
Provisional Application 61472516 · Apr 6, 2011
Provisional Application 61471236 · Apr 4, 2011
Related Publication 20140178963A1 · Jun 26, 2014
Related Publication 20200190502A9 · Jun 18, 2020
Cited By (3)
US 12,195,728 US 12,415,868 US 12,491,259